
STAAR Surgical (STAA) Stock Forecast & Price Target
STAAR Surgical (STAA) Analyst Ratings
Bulls say
Staar Surgical Co. is well-positioned for sustained above-market volume growth, particularly with the anticipated domestic launch of the EVO lens and increased adoption both domestically and internationally. The company is actively streamlining its operations to enhance revenue growth and improve its cost structure, which suggests a commitment to financial discipline and strategic investment. Furthermore, strong bull case assumptions project revenue growth exceeding 10%, supported by improved operating expense leverage, indicating the potential for significant earnings growth and margin improvements.
Bears say
The analysis indicates a negative outlook for Staar Surgical's stock based on several fundamental factors. Revenue growth is projected to remain flat or decline, particularly due to weaknesses in the Chinese market and challenges in the broader macroeconomic environment, which may significantly impact sales. Additionally, the company faces risks related to customer concentration, disappointing product launches, competition from lower-cost alternatives, and an increasing prevalence of myopia control products, all of which contribute to concerns about future financial performance.
This aggregate rating is based on analysts' research of STAAR Surgical and is not a guaranteed prediction by Public.com or investment advice.
STAAR Surgical (STAA) Analyst Forecast & Price Prediction
Start investing in STAAR Surgical (STAA)
Order type
Buy in
Order amount
Est. shares
0 shares